Analyzing CVS Health – A Closer Look at CVS Stock

By Blake Campbell • Friday, April 05 15:11 • Permanent Link

More and more people are talking about CVS Health over the last few weeks. Is it worth buying the Pharmaceutical Retail stock at a price of $74.7? Only time will tell. The information below will give you a basic idea of what this investment may entail:

CVS Health has moved -2.8% over the last year, and the S&P 500 logged a change of 25.3%
CVS has an average analyst rating of buy and is -14.73% away from its mean target price of $87.6 per share
Its trailing earnings per share (EPS) is $6.47
CVS Health has a trailing 12 month Price to Earnings (P/E) ratio of 11.5 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $9.19 and its forward P/E ratio is 8.1
The company has a Price to Book (P/B) ratio of 1.26 in contrast to the S&P 500's average ratio of 2.95
CVS Health is part of the Consumer Staples sector, which has an average P/E ratio of 21.21 and an average P/B of 4.12
CVS has reported YOY quarterly earnings growth of -10.5% and gross profit margins of 0.1%
The company has a free cash flow of $11.08 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.